京新药业“以人为本”，造就了一支朝气蓬勃的高素质的科研和管理队伍，并与中国科学院上海有机化学研究所、中科院上海药物所、中国医学科学院生物技术研究所、湖南省医药工业研究所等国内著名科研机构建立了长期友好的合作关系，现已成功开发了3项国家重点新产品，16项国家级新药，正在开发的国家新药（包括一类，二类）近10项。 R&D > Jingxin Pharm has successfully established long-term cooperative relations with the Shanghai Institute of Organic Chemistry, which is the most famous institute dealing with the research and development of new drugs in China. Jingxin also has established its institute to develop new drugs and supply the workshop with more advanced manufacturing techniques. At present, Jingxin’s R&D consists of three institutes: Xinchang Drug Research and Development Centre, Hangzhou Drug Resarch institute and Shanghai Drug Research and Development institute. Up to now Jingxin has developed 3 important novel products and 16 new drugs. And 10 new drugs are being developed. Jingxin Pharm is now aiming at the natural drugs with intellectual property rights, such as antineoplastics, and drugs for cardiovascular discases. The new antineoplastic, achyranthan (a national key modernization item of traditional Chinese medicine) has successfully been developed by the company.